Skip to main content

Advertisement

SpringerLink
Log in

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

The incidence of basal cell carcinoma (BCC) is significantly reduced in individuals treated with inhibitors of angiotensin I-converting enzyme (ACE) that produces angiotensin II. The objective of this study was to investigate the possible association of a functional polymorphism in the ACE gene, which affects its transcription, with risk for BCC. In DNA samples of 92 patients with BCC and 103 healthy controls of Greek origin and comparable age and gender, we studied the ACE gene insertion/deletion (I/D) polymorphism. Fisher’s exact test was used for comparison of allele and genotype frequencies between the control and patients’ groups. The detected low expression I allele frequency in the group of BCC patients was significantly decreased compared to controls (15.8 vs. 31.1 %, respectively; P = 0.001). ID heterozygotes exhibited 3.06 times lower BCC risk, compared with DD homozygotes (P = 0.001; OR = 0.327, 95 % CI = 0.174–0.615). The protective role of I allele was particularly prominent in women (P = 0.007, OR = 0.299, 95 % CI = 0.125–0.716), while for men it exhibited a marginal level (P = 0.041). These findings indicate that the low expression ACE I allele carriers have a decreased risk for BCC. The protective effect of the ID genotype against BCC may be explained by a possible underlying mechanism involving the effect of produced angiotensin II levels on its receptors due to putatively different binding affinity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ager EI, Neo J, Christophi C (2008) The renin-angiotensin system and malignancy. Carcinogenesis 29(9):1675–1684

    Article  PubMed  CAS  Google Scholar 

  2. Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH (2005) An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Arch Dermatol Res 297(2):94–98

    Article  PubMed  CAS  Google Scholar 

  3. Arnon O, Mamelak AJ, Goldberg LH (2008) Basal cell carcinoma arising in a patient with vitiligo. J Drugs Dermatol 7(11):1075–1076

    PubMed  Google Scholar 

  4. Aroni K, Ioannidis E, Voudouris S, Yapijakis C (2011) Homocysteinemia-associated anetoderma, in a young woman with anorexia nervosa history. Int J Dermatol 50:343–345

    Article  PubMed  CAS  Google Scholar 

  5. Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T (2003) Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 93(5):438–447

    Article  PubMed  CAS  Google Scholar 

  6. Bosnyak S, Jones ES, Christopoulos A, Aguilar MI, Thomas WG, Widdop RE (2011) Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci 121(7):297–303

    PubMed  CAS  Google Scholar 

  7. Carter DM, Lin AN (1993) Basal cell carcinoma. In: Fitzpatrick TM, Eisen AZ, Wolff K (eds) Dermatology in general medicine, 4th edn. McGraw-Hill, New York, pp 840–847

    Google Scholar 

  8. Chow L, Rezmann L, Catt KJ, Louis WJ, Frauman AG, Nahmias C, Louis SN (2009) Role of the renin-angiotensin system in prostate cancer. Mol Cell Endocrinol 302(2):219–229

    Article  PubMed  CAS  Google Scholar 

  9. Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA, VATTC Trial Group (2008) Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst 100(17):1223–1232

    Article  PubMed  CAS  Google Scholar 

  10. Chung FM, Yang YH, Chen CH, Lin CC, Shieh TY (2005) Angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers. Br J Cancer 93:602–606

    Article  PubMed  CAS  Google Scholar 

  11. Cocoş R, Schipor S, Nicolae I, Thomescu C, Raicu F (2012) Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G > C PTGS2 polymorphism and NMSC risk. Arch Dermatol Res 304(5):335–342

    Article  PubMed  Google Scholar 

  12. Crowson AN (2006) Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 19(Suppl 2):S127–S147

    Article  PubMed  Google Scholar 

  13. Crowson AN, Magro CM, Kadin M, Stranc M (1996) Differential expression of bcl-2 oncogene in human basal cell carcinoma. Hum Pathol 27:355–359

    Article  PubMed  CAS  Google Scholar 

  14. Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ (2010) Basal cell carcinoma: what’s new under the sun. Photochem Photobiol 86(3):481–491

    Article  PubMed  CAS  Google Scholar 

  15. Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105(2):141–145

    PubMed  CAS  Google Scholar 

  16. Fleming I (2006) Signaling by the angiotensin-converting enzyme. Circ Res 98(7):887–896

    Article  PubMed  CAS  Google Scholar 

  17. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA (1996) Angiotensin-(1–7) inhibits vascular smooth muscle cell growth. Hypertension 28(1):104–108

    Article  PubMed  CAS  Google Scholar 

  18. Freitas-Silva M, Pereira D, Coelho C, Bicho M, Lopes C, Medeiros R (2004) Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogen 155:42–46

    Article  CAS  Google Scholar 

  19. Friis S, Sorensen HT, Mellemkjaer L, McLaughlin JK, Nielsen GL, Blot WJ, Olsen JH (2001) Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer 92(9):2462–2470

    Article  PubMed  CAS  Google Scholar 

  20. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M (2002) Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294:441–447

    Article  PubMed  CAS  Google Scholar 

  21. Gerstenblith MR, Shi J, Landi MT (2010) Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis. Pigment Cell Melanoma Res 23(5):587–606

    Article  PubMed  CAS  Google Scholar 

  22. Goldberg LH (1996) Basal cell carcinoma. Lancet 347:663–667

    Article  PubMed  CAS  Google Scholar 

  23. Goldstein AM, Bale SJ, Peck GL, DiGiovanna JJ (1993) Sun exposure and basal cell carcinoma in the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol 29:34–41

    Article  PubMed  CAS  Google Scholar 

  24. Goto Y, Ando T, Nishio K, Ishida Y, Kawai S, Goto H, Hamajima N (2005) The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 6(4):464–467

    PubMed  Google Scholar 

  25. Haiman C, Henderson S, Bretsky P, Kolonel L, Henderson B (2003) Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 63:6984–6987

    PubMed  CAS  Google Scholar 

  26. He C, Qureshi AA, Han J (2010) Polymorphisms in genes involved in oxidative stress and their interactions with lifestyle factors on skin cancer risk. J Dermatol Sci 60(1):54–56

    Article  PubMed  CAS  Google Scholar 

  27. Iwasaki JK, Srivastava D, Moy RL, Lin HJ, Kouba DJ (2012) The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics. J Am Acad Dermatol 66(5):167–178

    Article  Google Scholar 

  28. Jackson A, Brown K, Langdown J, Luddington R, Baglin T (2000) Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol 111(2):562–564

    Article  PubMed  CAS  Google Scholar 

  29. Johnson TM, Tschen J, Ho C, Lowe L, Nelson BR (1994) Unusual basal cell carcinomas. Cutis 54:85–92

    PubMed  CAS  Google Scholar 

  30. Kosiniak-Kamysz A, Pośpiech E, Wojas-Pelc A, Marcińska M, Branicki W (2012) Potential association of single nucleotide polymorphisms in pigmentation genes with the development of basal cell carcinoma. J Dermatol doi:10.1111/j.1346-8138.2012.01559.x

  31. Krüger K, Blume-Peytavi U, Orfanos CE (1999) Basal cell carcinoma possibly originates from the outer root sheath and/or the bulge region of the vellus hair follicle. Arch Dermatol Res 291(5):253–259

    Article  PubMed  Google Scholar 

  32. Lacour JP (2002) Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 146(Suppl 61):17–19

    Article  PubMed  CAS  Google Scholar 

  33. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW (1998) Do inhibitors of angiotensin-I converting enzyme protect against risk of cancer? Lancet 352(9123):179–184

    Article  PubMed  CAS  Google Scholar 

  34. Medeiros R, Vasconcelos A, Costa S, Pinto D, Lobo F, Morais A, Oliveira J, Lopes C (2004) Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202:330–335

    Article  PubMed  CAS  Google Scholar 

  35. McKenzie CA, Julier C, Forrester T, McFarlane-Anderson N, Keavney B, Lathrop GM, Ratcliffe PJ, Farrall M (1995) Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 57:1426–1435

    PubMed  CAS  Google Scholar 

  36. Miller SJ (1991) Biology of basal cell carcinoma (Part I). J Am Acad Dermatol 24:1–13

    Article  PubMed  CAS  Google Scholar 

  37. Miller SJ (1991) Biology of basal cell carcinoma (Part II). J Am Acad Dermatol 24:161–175

    Article  PubMed  CAS  Google Scholar 

  38. Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774–778

    Article  PubMed  CAS  Google Scholar 

  39. Moscarelli L, Zanazzi M, Mancini G, Rossi E, Caroti L, Rosso G, Bertoni E, Salvadori M (2010) Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients. Clin Nephrol 73(6):439–445

    PubMed  CAS  Google Scholar 

  40. Nan H, Xu M, Kraft P, Qureshi AA, Chen C, Guo Q, Hu FB, Curhan G, Amos CI, Wang LE, Lee JE, Wei Q, Hunter DJ, Han J (2011) Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet 20(18):3718–3724

    Article  PubMed  CAS  Google Scholar 

  41. Porrello ER, Pfleger KD, Seeber RM, Qian H, Oro C, Abogadie F, Delbridge LM, Thomas WG (2011) Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles. Cell Signal 23(11):1767–1776

    Article  PubMed  CAS  Google Scholar 

  42. Rao BK, Freeman RG, Poulos EG, Arbesfeld L, Rendon M (1994) The relationship between basal cell epithelioma and seborrheic keratosis. J Dermatol Surg Oncol 20:761–764

    PubMed  CAS  Google Scholar 

  43. Rocken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, Krüger S, Malfertheiner P, Roessner A, Ebert MP (2005) The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 11(7):2526–2530

    Article  PubMed  Google Scholar 

  44. Rodgers K, Xiong S, Felix J, Roda N, Espinoza T, Maldonado S, Dizerega G (2001) Development of angiotensin (1–7) as an agent to accelerate dermal repair. Wound Repair Regen 9(3):238–247

    Article  PubMed  CAS  Google Scholar 

  45. Rustemeyer J, Günther L, Deichert L (2011) A rare association: basal cell carcinoma in a vitiliginous macula. Oral Maxillofac Surg 15(3):175–177

    Article  PubMed  Google Scholar 

  46. Scherer D, Kumar R (2010) Genetics of pigmentation in skin cancer—a review. Mutat Res 705(2):141–153

    Article  PubMed  CAS  Google Scholar 

  47. Sipahi I, Chou J, Mishra P, Debanne SM, Simon DI, Fang JC (2011) Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk. Am J Cardiol 108(2):294–301

    Article  PubMed  CAS  Google Scholar 

  48. Small W, Molteni A, Kim YT, Taylor JM, Chen Z, Ward WF (1997) Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture. Breast Cancer Res Treat 44(3):217–224

    Article  PubMed  CAS  Google Scholar 

  49. Steckelings UM, Wollschläger T, Peters J, Henz BM, Hermes B, Artuc M (2004) Human skin: source of and target organ for angiotensin II. Exp Dermatol 13(3):148–154

    Article  PubMed  CAS  Google Scholar 

  50. Stroth U, Unger T (1999) The renin angiotensin system and its receptors. J Cardiovasc Pharmacol 33:21–28

    Article  Google Scholar 

  51. Takeda H, Katagata Y, Kondo S (2002) Immunohistochemical study of angiotensin receptors in human anagen hair follicles and basal cell carcinoma. Br J Dermatol 147(2):276–280

    Article  PubMed  CAS  Google Scholar 

  52. Tanioka M, Takahashi K, Kawabata T, Kosugi S, Murakami K, Miyachi Y, Nishigori C, Iizuka T (2005) Germline mutations of the PTCH gene in Japanese patients with nevoid basal cell carcinoma syndrome. Arch Dermatol Res 296(7):303–308

    Article  PubMed  CAS  Google Scholar 

  53. Thomas WG (1999) Regulation of angiotensin II type 1 (AT1) receptor function. Regul Pept 79(1):9–23

    Article  PubMed  CAS  Google Scholar 

  54. Tsezou A, Karayannis G, Giannatou E, Papanikolaou V, Triposkiadis F (2008) Association of renin-angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population. J Renin Angiotensin Aldosterone Syst 9(4):202–207

    Article  PubMed  CAS  Google Scholar 

  55. Vairaktaris E, Yapijakis C, Tsigris C, Vassiliou S, Derka S, Nkenke E, Spyridonidou S, Vylliotis A, Vorris E, Ragos V, Neukam FW, Patsouris E (2007) Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 46(8):1097–1102

    Article  PubMed  CAS  Google Scholar 

  56. van Rossum MM, Wopereis D, Hoyer T, Soerjomataram I, Schalkwijk J, van de Kerkhof PC, Kiemeney LA, Hoogerbrugge N (2009) Incidence of cancer in first-degree relatives of basal cell carcinoma patients. Arch Dermatol Res 301(4):295–299

    Article  PubMed  Google Scholar 

  57. Wilkening S, Hemminki K, Rudnai P, Gurzau E, Koppova K, Kumar R, Försti A (2006) Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA. Br J Dermatol 155(6):1139–1144

    Article  PubMed  CAS  Google Scholar 

  58. Wu J, Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K, Müller-Esterl W, Maeda H (2002) Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 98:29–35

    Article  PubMed  CAS  Google Scholar 

  59. Yamada T, Horiuchi M, Morishita R, Zhang L, Pratt RE, Dzau VJ (1995) In vivo identification of a negative regulatory element in the mouse rennin gene using direct gene transfer. J Clin Invest 96(3):1230–1237

    Article  PubMed  CAS  Google Scholar 

  60. Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Tsujinoue H, Imazu H, Fukui H (2002) Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol 20:1227–1231

    PubMed  CAS  Google Scholar 

  61. Zemtsov A (2010) Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer. Arch Dermatol Res 302(3):169–170

    Article  PubMed  CAS  Google Scholar 

  62. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, Schunkert H, Doering A, Jacob HJ, Cooper RS, Rieder MJ (2000) Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 67(5):1144–1153

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank all individuals (BCC patients and healthy subjects) who participated in this study.

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, University of Athens Medical School, “Attikon” Hospital, Rimini 1, 12461, Athens, Greece

    Christos Yapijakis, Nikolas Koronellos, Sofia Spyridonidou, Antonis Vylliotis, Dimitris Avgoustidis & Eleftherios Vairaktaris

  2. Department of Neurology, University of Athens Medical School, “Eginition” Hospital, Athens, Greece

    Christos Yapijakis

  3. Department of Histopathology, University of Athens Medical School, “Evgenidion” Hospital, Athens, Greece

    Nikolaos Goutas & Dimitris Vlachodimitropoulos

Authors
  1. Christos Yapijakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolas Koronellos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sofia Spyridonidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonis Vylliotis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dimitris Avgoustidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nikolaos Goutas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dimitris Vlachodimitropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eleftherios Vairaktaris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christos Yapijakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yapijakis, C., Koronellos, N., Spyridonidou, S. et al. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma. Arch Dermatol Res 305, 333–339 (2013). https://doi.org/10.1007/s00403-012-1312-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-012-1312-7

Keywords

Search

Navigation